Koninklijke Philips NV PHIA

Morningstar Rating
€21.14 −0.16 (0.75%)
View Full Chart

Company Report

Philips Sees Stable Demand and Mitigates Rising Input Costs Through Controls

Philips is one of the leaders in imaging and image-guided therapies. But the company's track record is checkered, with multiple self-induced missteps tarnishing its reputation and investor confidence. We believe the resolution of sleep care problems, focus on its high-performing areas, and new management team should be able to change the narrative, but uncertainty remains.

Price vs Fair Value

PHIA is trading at a LOCK|Fmb premium.
Price
€21.14
Fair Value
!!
Uncertainty
LOCK|M%
1-Star Price
LOCK|.PR
5-Star Price
v!$
Economic Moat
LOCK|vD
Capital Allocation
LOCK|$D

Bulls Say, Bears Say

Bulls

Philips is the first to market with its helium-free 3.0T MR, which should help it recover some market share losses following its supply chain issues.

Bears

China's return to prominence is highly uncertain. Philips has an outsize exposure to this market, both in imaging and personal health.

News

Trading Information

Previous Close Price
€21.30
Day Range
€21.1421.56
52-Week Range
€20.9027.70
Bid/Ask
€21.12 / €21.59
Shares Outstanding
977.43M
Market Cap
€20.66B
Volume/Avg
2M / 2M

Key Statistics

Price/Earnings (Normalized)
11.62
Price/Sales
1.16
Dividend Yield (Trailing)
4.02%
Dividend Yield (Forward)
4.02%
Dividend Payment Schedule
Jun
Total Yield
4.22%

Company Profile

Koninklijke Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Nearly 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound and X-ray equipment, and image-guided therapy solutions. The connected care segment (under 30% of revenue) encompasses monitoring and analytics systems for hospitals, informatics business, and also houses the sleep and respiratory care segment. Personal health business (remainder of revenue) is mainly oral health and personal care product lines, which include electric toothbrushes and men's grooming and personal-care products.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Large Value
Total Number of Employees
63,670

Competitors

Valuation

Metric
PHIA
GEHC
RMD
Price/Earnings (Normalized)
11.6213.8118.38
Price/Book Value
1.782.634.57
Price/Sales
1.161.375.30
Price/Cash Flow
8.0812.3315.95
Price/Earnings
PHIA
GEHC
RMD

Financial Strength

Metric
PHIA
GEHC
RMD
Quick Ratio
0.730.841.83
Current Ratio
1.261.263.10
Interest Coverage
5.517.15
Quick Ratio
PHIA
GEHC
RMD

Profitability

Metric
PHIA
GEHC
RMD
Return on Assets (Normalized)
6.09%5.78%19.09%
Return on Equity (Normalized)
14.83%20.45%25.91%
Return on Invested Capital (Normalized)
9.41%11.38%22.30%
Return on Assets
PHIA
GEHC
RMD

Medical Devices Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Abbott Laboratories
ABT
LOCK|C<%CXx#LOCK|%LGJK$176B
Medtronic PLC
MDT
LOCK|qZF&>gLOCK|K<^s?$116B
Stryker Corp
SYK
LOCK|s$q>$$&LOCK|Kw$106B
Boston Scientific Corp
BSX
LOCK|b^cWh!DLOCK|#pHK$62B
Edwards Lifesciences Corp
EW
LOCK|@GqdZTJ!LOCK|#b?bK$49B
DexCom Inc
DXCM
LOCK|SCF$s$>LOCK|T!@N$31B
GE HealthCare Technologies Inc Common Stock
GEHC
LOCK|HCS#gt$LOCK|<&$29B
Koninklijke Philips NV ADR
PHG
LOCK|G$dLOCK|V&$24B
Steris PLC
STE
LOCK|cq<H$>LOCK|>JNxs$21B
Zimmer Biomet Holdings Inc
ZBH
LOCK|pgyRgTGLOCK|!N$18B

Sponsor Center